Christopher F. Carpenter
Infectious Disease
3535 West 13 Mile Road
Suite 605
Royal Oak, MI 48073
Suite 605
Royal Oak, MI 48073
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.
Journal: PharmacoEconomics - open
Published: August 24, 2023
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
Journal: Human vaccines & immunotherapeutics
Published: March 07, 2023
Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.
Journal: International journal of general medicine
Published: February 04, 2021
A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia.
Journal: Open forum infectious diseases
Published: January 29, 2019
Zika virus and pregnancy.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: June 11, 2016
The Zika virus and pregnancy: evidence, management, and prevention.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: April 08, 2016
Showing 1-6 of 6
Last Updated: 09/26/2026